iSpecimen Inc
NASDAQ:ISPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
iSpecimen Inc
Cash & Cash Equivalents
iSpecimen Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
iSpecimen Inc
NASDAQ:ISPC
|
Cash & Cash Equivalents
$6.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash & Cash Equivalents
$1.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
27%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash & Cash Equivalents
$104.8m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash & Cash Equivalents
$209.6m
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Cash & Cash Equivalents
$196.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
9%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Cash & Cash Equivalents
$61.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
iSpecimen Inc
Glance View
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.
See Also
What is iSpecimen Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.9m
USD
Based on the financial report for Dec 31, 2025, iSpecimen Inc's Cash & Cash Equivalents amounts to 6.9m USD.
What is iSpecimen Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
58%
Over the last year, the Cash & Cash Equivalents growth was 266%. The average annual Cash & Cash Equivalents growth rates for iSpecimen Inc have been -23% over the past three years , 58% over the past five years .
